Trial intelligence / Profile preview

Intradermal ketamine versus lidocaine versus saline for pain during intravenous venipuncture

IRCT20200707048047N2Phase 3Completed

Sponsor
Islamic Azad University
Start
Jun 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of ketamine, lidocaine and Normal Saline-Benha University (3 arms), sponsored by Islamic Azad University. Primary endpoints: Pain caused by venipuncture and Heart rate. Started Jun 2022; status: completed.

02

Drugs

ketaminelidocaineNormal Saline-Benha University

Beyond the preview

Go deeper on IRCT20200707048047N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20200707048047N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call